Patricia L. Morris

Array ( [id] => 4955639 [patent_doc_number] => 20080188663 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-07 [patent_title] => 'Process for the preparation of crystalline clopidogrel hydrogen sulphate Form I' [patent_app_type] => utility [patent_app_number] => 12/010581 [patent_app_country] => US [patent_app_date] => 2008-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5165 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0188/20080188663.pdf [firstpage_image] =>[orig_patent_app_number] => 12010581 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4445033 [patent_doc_number] => 07863300 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-04 [patent_title] => 'Process to prepare pioglitazone via several novel intermediates' [patent_app_type] => utility [patent_app_number] => 12/010473 [patent_app_country] => US [patent_app_date] => 2008-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19256 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/863/07863300.pdf [firstpage_image] =>[orig_patent_app_number] => 12010473 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4899910 [patent_doc_number] => 20080119524 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-22 [patent_title] => 'PRENYLATION INHIBITORS CONTAINING DIMETHYLCYCLOBUTANE AND METHODS OF THEIR SYNTHESIS AND USE' [patent_app_type] => utility [patent_app_number] => 12/020475 [patent_app_country] => US [patent_app_date] => 2008-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 16417 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20080119524.pdf [firstpage_image] =>[orig_patent_app_number] => 12020475 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4765693 [patent_doc_number] => 20080176905 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'Polymorphic forms of rosiglitazone hydrobromide and processes for preparation thereof' [patent_app_type] => utility [patent_app_number] => 12/009876 [patent_app_country] => US [patent_app_date] => 2008-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6015 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20080176905.pdf [firstpage_image] =>[orig_patent_app_number] => 12009876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8352239 [patent_doc_number] => 08247567 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-21 [patent_title] => 'Process for solvent removal from omeprazole salts' [patent_app_type] => utility [patent_app_number] => 12/523025 [patent_app_country] => US [patent_app_date] => 2008-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9058 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12523025 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4873781 [patent_doc_number] => 20080200515 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-21 [patent_title] => 'SOLID STATE FORMS OF ENANTIOPURE ILAPRAZOLE' [patent_app_type] => utility [patent_app_number] => 11/966808 [patent_app_country] => US [patent_app_date] => 2007-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 10553 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20080200515.pdf [firstpage_image] =>[orig_patent_app_number] => 11966808 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4873783 [patent_doc_number] => 20080200517 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-21 [patent_title] => 'CRYSTALLINE FORMS OF SOLVATED ILAPRAZOLE' [patent_app_type] => utility [patent_app_number] => 11/966896 [patent_app_country] => US [patent_app_date] => 2007-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 9424 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20080200517.pdf [firstpage_image] =>[orig_patent_app_number] => 11966896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4619390 [patent_doc_number] => 07999110 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-16 [patent_title] => 'Solid state forms of racemic ilaprazole' [patent_app_type] => utility [patent_app_number] => 11/966868 [patent_app_country] => US [patent_app_date] => 2007-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 57 [patent_figures_cnt] => 57 [patent_no_of_words] => 20567 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/999/07999110.pdf [firstpage_image] =>[orig_patent_app_number] => 11966868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4699145 [patent_doc_number] => 20080221329 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-11 [patent_title] => 'Novel and economical process for preparing (S, S)-2, 8-diazabicyclo[4.3.0]nonane and its enantiomer' [patent_app_type] => utility [patent_app_number] => 12/004822 [patent_app_country] => US [patent_app_date] => 2007-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4790 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20080221329.pdf [firstpage_image] =>[orig_patent_app_number] => 12004822 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10828804 [patent_doc_number] => RE045198 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2014-10-14 [patent_title] => 'Omeprazole solution and method for using same' [patent_app_type] => reissue [patent_app_number] => 11/960934 [patent_app_country] => US [patent_app_date] => 2007-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 3 [patent_no_of_words] => 10919 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11960934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6597067 [patent_doc_number] => 20100048639 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'OXADIAZOLE DERIVATES AS S1P1 RECEPTOR AGONISTS' [patent_app_type] => utility [patent_app_number] => 12/520137 [patent_app_country] => US [patent_app_date] => 2007-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19396 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20100048639.pdf [firstpage_image] =>[orig_patent_app_number] => 12520137 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4677195 [patent_doc_number] => 20080214826 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'PROCESSES FOR THE MANUFACTURE OF A PYRROLIDINE-3,4-DICARBOXAMIDE DERIVATIVE' [patent_app_type] => utility [patent_app_number] => 11/959486 [patent_app_country] => US [patent_app_date] => 2007-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18892 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20080214826.pdf [firstpage_image] =>[orig_patent_app_number] => 11959486 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6629748 [patent_doc_number] => 20100004293 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'CRYSTALLINE FORMS OF ARYL-SUBSTITUTED PYRAZOLE-AMIDE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/518490 [patent_app_country] => US [patent_app_date] => 2007-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 18873 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20100004293.pdf [firstpage_image] =>[orig_patent_app_number] => 12518490 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4753284 [patent_doc_number] => 20080161359 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'CRYSTALLINE FORM OF RABEPRAZOLE SODIUM' [patent_app_type] => utility [patent_app_number] => 11/958881 [patent_app_country] => US [patent_app_date] => 2007-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 1792 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20080161359.pdf [firstpage_image] =>[orig_patent_app_number] => 11958881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4808161 [patent_doc_number] => 20080171739 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-17 [patent_title] => 'Heteroaryl-Substituted Amides Comprising A Saturated Linker Group, And Their Use As Pharmaceuticals' [patent_app_type] => utility [patent_app_number] => 11/958483 [patent_app_country] => US [patent_app_date] => 2007-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37974 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20080171739.pdf [firstpage_image] =>[orig_patent_app_number] => 11958483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6638435 [patent_doc_number] => 20100173944 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'HELICOBACTER PYLORI ERADICATING AGENT HAVING INHIBITORY ACTIVITY ON GASTRIC ACID SECRETION' [patent_app_type] => utility [patent_app_number] => 12/519453 [patent_app_country] => US [patent_app_date] => 2007-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 17462 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20100173944.pdf [firstpage_image] =>[orig_patent_app_number] => 12519453 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7550743 [patent_doc_number] => 08063076 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-22 [patent_title] => 'Solid forms of 2-Chloro-4-[1-(4-fluoro-phenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl]-pyridine' [patent_app_type] => utility [patent_app_number] => 11/957515 [patent_app_country] => US [patent_app_date] => 2007-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 5837 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/063/08063076.pdf [firstpage_image] =>[orig_patent_app_number] => 11957515 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5586053 [patent_doc_number] => 20090105255 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'GLUCOKINASE ACTIVATORS' [patent_app_type] => utility [patent_app_number] => 11/958271 [patent_app_country] => US [patent_app_date] => 2007-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 70267 [patent_no_of_claims] => 86 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20090105255.pdf [firstpage_image] =>[orig_patent_app_number] => 11958271 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7762884 [patent_doc_number] => 08115006 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-14 [patent_title] => 'Process for producing anthranilamide compound' [patent_app_type] => utility [patent_app_number] => 12/519177 [patent_app_country] => US [patent_app_date] => 2007-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24688 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/115/08115006.pdf [firstpage_image] =>[orig_patent_app_number] => 12519177 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7519063 [patent_doc_number] => 07973165 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-05 [patent_title] => 'Imidazole derivatives' [patent_app_type] => utility [patent_app_number] => 11/955421 [patent_app_country] => US [patent_app_date] => 2007-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11195 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/973/07973165.pdf [firstpage_image] =>[orig_patent_app_number] => 11955421 [rel_patent_id] =>[rel_patent_doc_number] =>)